A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Unresectable Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
- Status
- RECRUITING
- Phase
- PHASE1
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
- Status
- UNKNOWN
- Phase
- PHASE3
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Clinical Study of Precision TACE (P-TACE) With Surefire
- Status
- WITHDRAWN
- Phase
- NA
Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3